• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化用于体重管理的胰高糖素样肽-1(GLP-1)药物治疗中的营养、饮食及生活方式沟通:一项对注册营养师的定性研究

Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: A qualitative research study with registered dietitians.

作者信息

Despain David, Hoffman Brenda L

机构信息

School of Communication and Journalism, Stony Brook University, Stony Brook, NY, USA.

出版信息

Obes Pillars. 2024 Oct 13;12:100143. doi: 10.1016/j.obpill.2024.100143. eCollection 2024 Dec.

DOI:10.1016/j.obpill.2024.100143
PMID:39498283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11533596/
Abstract

BACKGROUND

This qualitative study used semi-structured interviews to examine registered dietitians' perspectives on diet, nutrition, and lifestyle communication for patients on GLP-1 medications for obesity management.

METHODS

Through in-depth interviews with registered dietitians, this research identifies elements that could improve both the efficacy of GLP-1 medication therapies and patient adherence.

RESULTS

indicate that a comprehensive approach, integrating patient communication with proactive management of side effects and ongoing lifestyle counseling, is essential for optimizing treatment outcomes.

CONCLUSION

Key findings include the importance of using visual and metaphorical aids to improve understanding, the necessity for structured lifestyle programs, and the pivotal role of personalized diet plans. These insights offer valuable directions for enhancing patient care and formulating clinical practices around the use of GLP-1 receptor agonist medications.

摘要

背景

这项定性研究采用半结构化访谈,以探究注册营养师对于使用GLP-1药物治疗肥胖症的患者在饮食、营养和生活方式沟通方面的看法。

方法

通过对注册营养师进行深入访谈,本研究确定了可提高GLP-1药物治疗疗效和患者依从性的因素。

结果

表明采用综合方法,将患者沟通与副作用的积极管理以及持续的生活方式咨询相结合,对于优化治疗效果至关重要。

结论

主要发现包括使用视觉和隐喻辅助工具以增进理解的重要性、结构化生活方式计划的必要性以及个性化饮食计划的关键作用。这些见解为加强患者护理以及围绕GLP-1受体激动剂药物的使用制定临床实践提供了有价值的指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3344/11533596/d97ea3312e98/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3344/11533596/d97ea3312e98/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3344/11533596/d97ea3312e98/ga1.jpg

相似文献

1
Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: A qualitative research study with registered dietitians.优化用于体重管理的胰高糖素样肽-1(GLP-1)药物治疗中的营养、饮食及生活方式沟通:一项对注册营养师的定性研究
Obes Pillars. 2024 Oct 13;12:100143. doi: 10.1016/j.obpill.2024.100143. eCollection 2024 Dec.
2
Different settings, different approaches: a qualitative comparison of Portuguese dietitians' beliefs, attitudes and practices about obesity in public and private settings.不同环境,不同方法:对公共和私人环境中葡萄牙营养师关于肥胖的信念、态度和实践进行定性比较。
Public Health Nutr. 2018 Feb;21(2):435-446. doi: 10.1017/S1368980017002543. Epub 2017 Oct 30.
3
Exploring Dietitians' Perspectives Toward Current Practices and Services in Relation to Irritable Bowel Syndrome Management in Clinical Settings Across the United Kingdom: A Qualitative Study.探索英国各地临床环境中营养师对肠易激综合征管理的现行做法和服务的看法:一项定性研究。
J Acad Nutr Diet. 2025 Mar;125(3):335-347. doi: 10.1016/j.jand.2024.07.169. Epub 2024 Jul 30.
4
Dietitians' perspectives on patient barriers and enablers to weight management: An application of the social-ecological model.营养师对患者进行体重管理的障碍和促进因素的看法:社会生态模型的应用。
Nutr Diet. 2019 Jul;76(3):353-362. doi: 10.1111/1747-0080.12510. Epub 2019 Jan 4.
5
Knowledge Translation and Evidence-Based Practice: A Qualitative Study on Clinical Dietitians' Perceptions and Practices in Switzerland.知识转化与循证实践:瑞士临床营养师认知与实践的定性研究。
J Acad Nutr Diet. 2019 Nov;119(11):1882-1889. doi: 10.1016/j.jand.2019.04.017. Epub 2019 Jul 8.
6
Exploring dietitians' practice and perspectives on the role of dietary patterns during cancer treatment: A qualitative study.探讨营养师在癌症治疗期间对饮食模式作用的实践和观点:一项定性研究。
PLoS One. 2024 May 14;19(5):e0302107. doi: 10.1371/journal.pone.0302107. eCollection 2024.
7
Linking active living and nutrition counselling: dietitians' perceptions.将积极生活方式与营养咨询相联系:营养师的看法。
Can J Diet Pract Res. 2004 Winter;65(4):154-60. doi: 10.3148/65.4.2004.154.
8
Dietitians' Perspectives on the Coordination and Continuity of Nutrition Care for Malnourished or Frail Clients: A Qualitative Study.营养师对营养不良或体弱客户营养护理协调与连续性的看法:一项定性研究
Healthcare (Basel). 2022 May 26;10(6):986. doi: 10.3390/healthcare10060986.
9
Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians' current practices.加拿大儿科苯丙氨酸羟化酶(PAH)缺乏症患者的营养管理:营养师当前实践情况调查。
Orphanet J Rare Dis. 2019 Jan 8;14(1):7. doi: 10.1186/s13023-018-0978-0.
10
Dietitians' Perspectives on the Impact of Multidisciplinary Teams and Electronic Medical Records on Dietetic Practice for Weight Management.营养师对多学科团队和电子病历对体重管理中饮食实践影响的看法。
Can J Diet Pract Res. 2020 Mar 1;81(1):2-7. doi: 10.3148/cjdpr-2019-015. Epub 2019 May 8.

引用本文的文献

1
Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study.使用胰高血糖素样肽-1受体激动剂期间的营养摄入调查:一项横断面研究。
Front Nutr. 2025 Apr 25;12:1566498. doi: 10.3389/fnut.2025.1566498. eCollection 2025.
2
What is the Role of Primary Prevention of Obesity in an Age of Effective Pharmaceuticals?在有效药物时代,肥胖一级预防的作用是什么?
Curr Obes Rep. 2025 May 7;14(1):39. doi: 10.1007/s13679-025-00632-0.

本文引用的文献

1
Nutritional considerations with antiobesity medications.抗肥胖药物的营养考虑因素。
Obesity (Silver Spring). 2024 Sep;32(9):1613-1631. doi: 10.1002/oby.24067. Epub 2024 Jun 10.
2
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.通过运动、胰高血糖素样肽-1受体激动剂或两者联合进行健康体重维持,随后一年不进行治疗:一项随机安慰剂对照试验的治疗后分析
EClinicalMedicine. 2024 Feb 19;69:102475. doi: 10.1016/j.eclinm.2024.102475. eCollection 2024 Mar.
3
GLP-1 Agonists for Obesity-A New Recipe for Success?
用于治疗肥胖症的胰高血糖素样肽-1激动剂——成功的新秘诀?
JAMA. 2024 Mar 26;331(12):1007-1008. doi: 10.1001/jama.2024.2252.
4
Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF.营养不良和肌肉减少症:在射血分数保留的心力衰竭中使用胰高血糖素样肽-1受体激动剂需谨慎的原因
J Card Fail. 2024 Apr;30(4):610-612. doi: 10.1016/j.cardfail.2024.01.005. Epub 2024 Feb 1.
5
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics.肥胖症治疗的新前沿:基于胰高血糖素样肽-1和新生营养刺激激素的疗法
Annu Rev Med. 2023 Jan 27;74:125-139. doi: 10.1146/annurev-med-043021-014919.
6
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus.管理接受胰高血糖素样肽-1受体激动剂治疗患者胃肠道不良事件的临床建议:多学科专家共识
J Clin Med. 2022 Dec 24;12(1):145. doi: 10.3390/jcm12010145.
7
Tirzepatide Once Weekly for the Treatment of Obesity.司美格鲁肽每周一次治疗肥胖症。
N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4.
8
Anti-diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications.抗糖尿病药物与肌肉减少症:新的关联、机制见解及临床意义。
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1368-1379. doi: 10.1002/jcsm.12838. Epub 2021 Oct 21.
9
Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.运动、利拉鲁肽或两者联合用于维持健康的体重减轻。
N Engl J Med. 2021 May 6;384(18):1719-1730. doi: 10.1056/NEJMoa2028198.
10
Patient-centered care: Dietitians' perspectives and experiences.以患者为中心的护理:营养师的观点和经验。
Patient Educ Couns. 2021 Nov;104(11):2724-2731. doi: 10.1016/j.pec.2021.04.008. Epub 2021 Apr 16.